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ABSTRACT 
Purpose: To investigate the effects of feedback, in the form of a virtual avatar paced at 100 and 102% 
of baseline performance, on neuromuscular fatigue following a 4 km cycling time trial (TT). We 
hypothesised that improved cycling performance would occur due to participants exceeding a 
previously established critical threshold, and experiencing greater neuromuscular fatigue. Methods: 
Following familiarisation, ten well-trained cyclists performed a baseline 4 km TT without feedback 
(BASE), followed by two, 4 km TT where they raced against an avatar (set at 100% [accurate - ACC] 
and 102% [deception - DEC] of baseline power output), in a randomised and counterbalanced order. 
Before and after each TT, neuromuscular fatigue was assessed using maximal isometric voluntary 
contractions (MVC) of the quadriceps, and supramaximal electrical stimulation of the femoral nerve, 
during and 2 s after MVCs to assess voluntary activation and potentiated twitch force. Blood lactate 
was taken pre- and post-trials and rating of perceived exertion (RPE) was taken throughout each TT. 
Results: TT performance improved following deception of feedback compared to baseline 
performance (−5.8 s, P = 0.019). Blood lactate increased following DEC compared to BASE (+1.37 
mmol·L-1, P = 0.019). Despite this, there was no difference in any measures of exercise-induced 
neuromuscular fatigue (P > 0.05). Similarly, RPE was not different between trials. Conclusion: Well-
trained male cyclists can improve cycling TT performance when competing against an avatar increased 
to 102% of a previously established best effort. However, this improvement is not associated with a 
measurable augmentation of neuromuscular fatigue. 
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INTRODUCTION 
The pacing strategy adopted during a cycling time trial (TT) is intended to optimize performance while 1 
minimizing fatigue (1, 2). Fatigue is a universal phenomenon characterized by sensations of tiredness 2 
and weakness during or following exertion, which is underpinned and/or modulated by multiple 3 
physiological and psychological processes. An acute bout of exercise, and the consequent disruption 4 
to homeostasis, is a particularly potent stimulus to elicit fatigue. The potential contributors to the 5 
fatigue experienced during cycling TT exercise include energy depletion (3), cardiorespiratory stress 6 
(4), disruption to peripheral homeostasis (5), reduced muscle activation (6), and muscle tissue damage 7 
(7), all of which contribute to reductions in the force producing capacity of working muscles. For 8 
locomotor exercise a common approach to understanding the etiology of fatigue involves assessment 9 
of the neuromuscular adjustments underpinning the post-exercise reduction the in voluntary force 10 
producing capabilities of the involved muscles (8-11). Such investigations have demonstrated that 11 
high-intensity cycling exercise elicits central (i.e., an inability to voluntarily activate muscle) and 12 
peripheral (i.e., decrements in measures of contractile function) fatigue which contributes to this 13 
voluntary force loss, termed muscle fatigue (6). The relative magnitude of central and peripheral 14 
adjustments varies depending on the intensity and duration of the cycling (10, 11). 15 
 16 
The contractile impairments observed after self-paced high-intensity cycling TTs are remarkably 17 
consistent between trials (12), with end-exercise quadriceps potentiated twitch force reductions of 18 
approximately 35% reported by numerous research groups (11-14). The magnitude of this reduction 19 
is consistent on repeated trials, and unaffected by pre-fatiguing exercise (15-17), or altered fractions 20 
of inspired oxygen (13). This phenomenon has been termed the ‘critical threshold of peripheral 21 
fatigue’ (12) and is believed to be a significant factor in high intensity exercise tolerance as participants 22 
cannot, or will not, voluntarily exceed this limit. However, such a critical threshold is specific to the 23 
task (12) and the unvarying degree of peripheral fatigue observed at the end of high-intensity self-24 
paced cycling does not represent an absolute limit for peripheral fatigue.  Rather, this supports the 25 
idea that exercisers maintain a “contractile reserve”, perhaps as a protective mechanism in response 26 
to the threat exercise poses to the health of the organism (12, 18).  Whether the exerciser can access 27 
this reserve under exceptional circumstances is debatable. Currently, the only evidence to suggest so 28 
are observations made when group III/IV afferent neurons are pharmaceutically blocked, enabling 29 
participants to willingly cycle past the point of peripheral fatigue attained when afferent feedback is 30 
intact (19, 20). This suggests a contractile reserve exists at task termination when afferent neurons 31 
are intact, which if accessible under normal conditions, could conceptually allow for a greater 32 
performance.  33 
 34 
One potential intervention that could motivate participants to tolerate a greater magnitude of 35 
peripheral fatigue, and thereby access a theoretical contractile reserve, is the provision of competition 36 
and/or surreptitious feedback. Previous literature investigating self-paced cycling has shown that 37 
performance is improved when receiving accurate feedback, or racing against a virtual avatar of a 38 
previous best performance (21, 22). Furthermore, Stone, Thomas (23) showed that when the speed 39 
of an avatar is surreptitiously increased by 2% (a “deception” trial), participants were able to improve 40 
cycling TT performance even further. Based on these findings, it could be suggested that the presence 41 
of an avatar increases motivation via an ego-orientated goal of beating the competition (24), which 42 
may enable athletes to tolerate a greater disruption to homeostasis, and the improved performance 43 
observed in these previous studies might have been associated with a higher-than-usual magnitude 44 
of neuromuscular fatigue. 45 
 46 
Two recent investigations have provided partial support to this notion. Konings, Parkinson (25) 47 
showed that participants completing a 4 km cycling TT against a virtual avatar of a previous 48 
performance, improved performance and experienced greater losses in MVC, and potentiated twitch 49 
force (indicative of peripheral fatigue). This increased magnitude of peripheral fatigue occurred whilst 50 
rating of perceived exertion (RPE) did not change between trials. The authors attributed this to a shift 51 
of focus from internal to external factors, distracting participants from the discomfort elicited by the 52 
higher exercise intensity, and altering the decision making process associated with pacing. 53 
Additionally, Ducrocq, Hureau (26) demonstrated that when performance of a 5 km TT is improved by 54 
provision of surreptitious feedback (a 2% deception trial,  similar to Stone, Thomas (23), (27)), 55 
participants experienced greater reductions in MVC, and increased central fatigue post-exercise, but 56 
no additional peripheral fatigue. During the deception trial greater motor unit recruitment of the 57 
quadriceps (increased electromyographic activity; rmsEMG) was also evident. These increases in 58 
rmsEMG have been previously suggested to have some association with the extent of anaerobic 59 
metabolism (28), which lends some support to the idea that deceiving participants could enable access 60 
to a previously protected metabolic reserve (23). Although reductions in voluntary force and voluntary 61 
activation were augmented with deceptive feedback, the involuntary twitch response to stimulation 62 
was not different between trials, indicating that a critical threshold of peripheral fatigue was not 63 
exceeded and a contractile reserve of the quadriceps was not utilized. 64 
 65 
The population tested in Ducrocq, Hureau (26) were recreationally active, and their performance of 5 66 
km TTs was modest (mean power output, 219 W). In contrast, well-trained cyclists would expect to 67 
attain a mean power output in excess of 330 W for the same TT (29). Similarly, despite Konings, 68 
Parkinson (25) stipulating that ‘trained athletes’ were tested, the mean power outputs reported for a 69 
4 km TT  (~280 W) would indicate this participant group were not well-trained cyclists (30). It has long 70 
been established that experienced, elite athletes employ different cognitive ‘coping’ strategies during 71 
endurance exercise to less experienced athletes (31), which might alter the motivational reaction to 72 
an avatar of either a previous best performance, or a deceptively increased performance. Therefore, 73 
previous findings related to the use of deceptive feedback and (25, 26) might not apply to well-trained 74 
endurance athletes, and it remains to be seen whether surreptitiously altered feedback improves 75 
performance by enabling the use of a contractile reserve in this population. Accordingly, the aim of 76 
the present study was to test the hypothesis that provision of surreptitious feedback during TT 77 
exercise in well-trained male cyclists would result in improved performance, and a concomitant 78 
greater magnitude of end-exercise peripheral fatigue. 79 
 80 
METHODS 81 
Participants 82 
Ten well-trained cyclists (mean ± SD age, 29 ± 8 years; stature, 180 ± 6 cm; mass, 73 ± 8 kg; maximum 83 
aerobic power, 405 ± 27 W; 5.6 ± 0.5 W·kg−1; maximum oxygen uptake, 67.9 ± 6.8 ml·kg−1·min−1) 84 
volunteered and gave written informed consent for the study. Participants were informed that the 85 
study aimed to assess the reliability of physiological and neuromuscular responses to 4 km TTs, and 86 
were informed of the deception after completion of the study. Institutional ethical approval was 87 
granted, and the study adhered to the Declaration of Helsinki. 88 
 89 
Experimental Design 90 
Participants visited the laboratory on 4 separate occasions to complete a preliminary visit (ramp test 91 
and practice 4 km TT), followed by three experimental, self-paced 4 km cycling trials. The first self-92 
paced trial was a 4 km TT to establish baseline performance. The final two visits were 4 km TT with 93 
either accurate or deceptive feedback, in a randomised and counterbalanced order. During all trials, 94 
participants were instructed to complete the distance as fast as possible. Each trial was scheduled for 95 
a similar time of day to account for diurnal variations in the cardiovascular and neuromuscular systems 96 
(32, 33). Prior to each experimental trial participants were asked to refrain from ingesting caffeine (12 97 
hours) and alcohol (24 hours), and performing strenuous exercise (24 hours).  98 
 99 
Procedures 100 
Preliminary visit 101 
Participants completed a ramp test and 4 km TT on a Velotron Pro cycling ergometer (Velotron Racer 102 
Mate, Seattle, USA). The ramp test involved a 10 minute warm up at 100 W followed by a continuous 103 
incremental ramp in power of 1 W every 2 s (30 W·min−1) to the limit of tolerance. The test was 104 
terminated when cadence reduced by 20 rpm below participants’ self-selected cadence. Expired air 105 
was analysed via an online breath by breath system (Oxycon Pro, Care Fusion, Hoechberg, Germany). 106 
Ventilatory volumes were inferred from the measurement of gas flow using a digital turbine 107 
transducer (volume, 0–10 L; resolution, 3 mL; flow, 0–15 L·s−1) attached to a mask. Maximum oxygen 108 
uptake (VO2max) was calculated as the highest 30 s mean value attained before test termination, and 109 
the end test power was recorded as maximum aerobic power (Pmax). A practice 4 km TT was included 110 
in the preliminary visit to familiarise participants with the exercise and thus limit learning effects in 111 
the experimental trials (29). 112 
 113 
Experimental Visits 114 
Participants completed three, 4 km TT. Before and immediately after each trial, a neuromuscular 115 
function assessment was completed (see below). All trials were completed following a standardised 116 
warm up (5 min at 150 W then 5 min at 70% Pmax followed by 5 min of rest). Ratings of perceived 117 
exertion (RPE) were obtained every km. Blood lactate was measured using 20 µL capillary blood 118 
samples taken from the fingertip 2 min prior to the start, and immediately post-trial (Biosen, EKF 119 
Diagnostic, Barleben, Germany). The first trial (baseline; BASE) was performed with participants 120 
shown their progress in real time on a screen via an avatar and a graphic showing distance covered. 121 
All other feedback was removed from the screen. The same flat course profile was used in all 122 
subsequent trials. The next two trials were performed with two avatars on screen; one showing their 123 
current performance, and a pacemaker avatar showing their baseline performance (accurate; ACC) or 124 
the baseline power output increased by 2% (deception; DEC). The 2% margin of increase was 125 
specifically chosen as it is the smallest worthwhile change in 4 km performance (29), thus providing 126 
the least chance of being detected by the participant. Provision of augmented feedback equating to a 127 
2% increase in power output has previously been successfully used to elicit performance 128 
improvements in well-trained cyclists performing similar TTs in our laboratory (23, 27). It was 129 
confirmed that participants believed they were racing their baseline performance in both 130 
experimental trials and none suspected the deception at any point throughout the study.  131 
 132 
Neuromuscular Function 133 
Neuromuscular function was assessed before and immediately after each TT. This consisted of 3 134 
maximal isometric knee-extensor contractions (MVC) separated by 30 s rest, with femoral nerve 135 
stimulation delivered at peak force and 2 s following each MVC to calculate voluntary activation (VA) 136 
and measure the potentiated quadriceps twitch force (Qtw,pot). Following task termination, each ‘post-137 
trial’ neuromuscular function assessment was completed in <1.5 min. 138 
 139 
Force and EMG Recording 140 
During the neuromuscular function assessments, participants sat upright in a custom built chair with 141 
hips and knees at 90˚ flexion. A calibrated load cell (MuscleLab force sensor 300, Ergotest Technology, 142 
Norway) was attached via a noncompliant cuff positioned on the participant’s right leg, superior to 143 
the malleoli, to measure knee extensor force (N). Surface Ag/AgCl electrodes (Kendall H87PG/F; 144 
Covidien, Mansfield, MA) were placed 2 cm apart over the vastus lateralis (VL) to record the 145 
compound muscle action potential (M-wave), elicited by the electrical stimulation of the femoral 146 
nerve. Skin was shaved and abraded to ensure minimal impedance, then electrodes were positioned 147 
according to the SENIAM guidelines, a reference electrode was placed over the patella. Electrode 148 
placement was marked with permanent ink to ensure a consistent placement between trials. Signals 149 
were amplified: (gain ×1000 for EMG and ×300 for force; CED 1902, Cambridge Electronic Design, 150 
Cambridge, UK), bandpass filtered (EMG only: 20–2000 Hz), digitized (4 kHz; CED 1401, Cambridge 151 
Electronic Design), and analysed offline (Spike2 v7.12, Cambridge Electronic Design).  152 
 153 
Motor Nerve Stimulation 154 
Single electrical stimuli (200 µs duration) were applied to the right femoral nerve using a constant-155 
current stimulator (DS7AH Digitimer Ltd., Welwyn Garden City, UK) via adhesive surface electrodes 156 
(CF3200; Nidd Valley Medical Ltd., Harrogate, UK) at rest, and during voluntary contractions. The 157 
cathode was positioned over the nerve high in the femoral triangle, in the location that elicited the 158 
maximum quadriceps twitch amplitude (Qtw) and the M-wave (Mmax) at rest. The anode was positioned 159 
midway between the greater trochanter and the iliac crest. The optimal stimulation intensity was 160 
determined as the minimum current that elicited maximum values of Qtw and Mmax at rest. To ensure 161 
a supramaximal stimulus, and to account for fatigue-dependent changes in axonal excitability, the 162 
intensity was increased by 30% and was not different between trials (171 ± 34, 167 ± 38, and 164 ± 29 163 
mA, P = 0.722).  164 
 165 
Data Analysis  166 
VA measured via motor nerve stimulation was quantified using the twitch interpolation method: VA 167 
(%) = (1 - [SIT ÷ Qtw,pot] × 100), where SIT is the mean amplitude of the superimposed twitch force 168 
measured during MVCs, and Qtw,pot is the mean amplitude of the resting quadriceps potentiated twitch 169 
force assessed 2 s post-MVC (34). The peak-to-peak amplitude and the area of the evoked Mmax 170 
responses were quantified offline. Cycling power output (W) was recorded during each TT and was 171 
averaged over 10% distance epochs. Between day reliability values (coefficient of variation – CV%) for 172 
MVC (4.3%), Qtw.pot (6.9%), and VA (1.7%) were calculated post hoc using the ‘pre’ data of the three 173 
experimental trials.  174 
 175 
Statistical Analysis 176 
Two-way (trial × time) repeated measures ANOVAs were used to assess within and between-trial 177 
differences in neuromuscular measures (MVC, Qtw,pot, Mmax amplitude and area, within twitch 178 
characteristics), and cycling performance (power). A one-way repeated measures ANOVA was 179 
conducted to assess between trial differences in time taken to complete the TT, and pre-post changes 180 
in blood lactate. For all parametric ANOVAs, Bonferroni pairwise comparison tests were run post-hoc 181 
when a significant main effect was observed. A Friedmann’s ANOVA with post hoc Wilcoxon signed-182 
ranks test was used for nonparametric data (RPE). The assumptions underpinning these statistical 183 
procedures were verified, and all data were considered normal. Descriptive data are presented as 184 
means ± SD in text, tables, and figures. Statistical significance was assumed at P ≤ 0.05. 185 
 186 
RESULTS 187 
Participant Characteristics 188 
Maximum aerobic power achieved during the initial ramp test was 5.3 ± 0.7 W·kg−1. According to De 189 
Pauw et al. (2013), the values placed 1 participant in the ‘trained’ category (4.6 W·kg−1), 7 participants 190 
in the ‘well-trained’ category (range: 4.6 – 5.5 W·kg−1), and 2 participants in the ‘professional’ category 191 
(range: 6.1 – 6.8 W·kg−1). 192 
 193 
 194 
 195 
4 km Time Trial Performance 196 
Time taken to complete 4 km TT was different between trials (BASE, 367 ± 15 s; ACC, 365 ± 18 s; DEC, 197 
361 ± 17 s; F2,20 = 5.40; P = 0.015; η2 = 0.375). Nine out of ten participants improved their 4 km TT 198 
during DEC compared to BASE (range: –2 to –15 s), with one recording an equal time. Eight participants 199 
were faster in DEC compared to ACC (range: –2 to –15 s), and two participants were not (range: 0 to 200 
+6 s). Pairwise comparisons revealed that DEC was faster than BASE (−5.80 ± 1.65 s; P = 0.019), 201 
however ACC was not (−1.70 ± 1.84 s; P = 1.000). There was no significant difference between DEC 202 
and ACC (−4.10 ± 1.94 s, P = 0.191; Table 1). Mean power profiles can be seen in Figure 1, the ANOVA 203 
revealed no significant effect between trials (BASE, 324 ± 38 W; ACC, 327 ± 42 W; DEC 334, ± 41 W; 204 
F2,20 = 0.569; P = 0.576; η2 = 0.059). And no interaction effect was shown (trial × time: F18,180 = 1.31; P 205 
= 0.186; η2 = 0.127). The increase in blood lactate (Table 1) was significantly different between trials 206 
(trial effect: F2,20 = 4.69; P = 0.014; η2 = 0.378). Pairwise comparisons revealed that blood lactate 207 
increased more in DEC than BASE (Δ13.71 vs. Δ12.34 mmol.L-1; P = 0.019), however, there was no 208 
difference between ACC and DEC or BASE (Δ13.09 vs Δ12.34mmol.L-1; P = 0.161). Mean RPE did not 209 
differ between trials (X22 = 1.04; P = 0.595). 210 
 211 
***TABLE 1 HERE*** 212 
***FIGURE 1 HERE*** 213 
 214 
Neuromuscular Function 215 
MVC force decreased in all trials (BASE: -21 ± 6%; ACC: -19 ± 6%; DEC -23 ± 7%; F2,20 = 226.40; P < 216 
0.001; η2 = 0.962). However, there was no trial (F2,20 = 0.45; P = 0.646; η2 = 0.0471) or trial × time 217 
interaction effect (F2,20 = 0.82; P = 0.456; η2 = 0.083, Figure 2, panel A). Voluntary activation showed 218 
the same pattern, decreasing from pre- to post-exercise (BASE: -14 ± 11%; ACC: -12 ± 9%; DEC -13 ± 219 
12%; F2,20 =18.61; P = 0.002; η2 = 0.674) with no difference in the response between trials (trial: F2,20 = 220 
0.70; P = 0.511; η2 = 0.072 and interaction effect: F2,20 = 0.191; P = 0.828 η2 = 0.021, Figure 2, panel B). 221 
Potentiated twitch force also declined in each trial (BASE: -34 ± 17%; ACC: -35 ± 12; DEC -41 ± 14%; 222 
time effect: F2,20 = 54.90; P < 0.001; η2 = 0.859), and similar to MVC and VA, there was no difference 223 
between trials (trial: F2,20 = 1.16; P = 0.337; η2 = 0.114, trial × time interaction: F2,20 = 1.25; P = 0.311; 224 
η2 = 0.122, Figure 2, panel C).  Evoked EMG variables (i.e., Mmax amplitude and area, Table 2) were not 225 
different between trials and did not change from pre- to post-trial (P > 0.05). Within twitch 226 
characteristics (Table 2) all decreased from pre- to post-trials (P < 0.05), however the degree of change 227 
was not different between trials (P > 0.05). 228 
***FIGURE 2 HERE*** 229 
***TABLE 2 HERE*** 230 
 231 
DISCUSSION 232 
The aim of the present study was to investigate whether improvements in 4 km TT performance 233 
elicited by deceptive feedback in well-trained cyclists, was associated with increased end-exercise 234 
peripheral fatigue. The present study shows that cycling performance was improved by competition 235 
against a virtual avatar surreptitiously changed to 102% of a previous best effort, but not against an 236 
avatar set at 100%. This improvement was accompanied by an increase in blood lactate at task 237 
completion and supports previous literature utilising this method to improve performance (23, 27). 238 
Despite the improvement in TT completion and increase in blood lactate in the deception trial, there 239 
was no augmentation of peripheral fatigue. Consequently, the hypothesis that performance 240 
improvements elicited by deceptive feedback can be explained by exceeding or altering a previously 241 
established critical threshold of peripheral fatigue is not supported by the present study. 242 
 243 
In contrast to our findings, Ducrocq, Hureau (26) and Kronings et al. (2017) reported greater decreases 244 
in neuromuscular function when competing against a virtual avatar and receiving deceptive feedback. 245 
Ducrocq, Hureau (26) showed a 2% improvement in completion time following the 102% pacemaker 246 
trial compared to the accurate feedback trial, with measures of maximum voluntary force decreasing 247 
an extra 5% (−41 vs. −36%) and voluntary activation an extra 4% (−18 vs. −14%) post-exercise. The 248 
authors suggested that the increased power output, cardiovascular response, and muscle activation 249 
during the deceptive trial led to increased metabolic work and consequently an accumulation of 250 
deleterious metabolites within the quadriceps. Despite this, and in agreement with the present study, 251 
the improved performance in the deceptive trial was not associated with any additional peripheral 252 
fatigue (reductions in potentiated twitch force); a measure of muscle function that does not rely on 253 
voluntary effort. This would suggest that a critical threshold for peripheral fatigue was not exceeded 254 
and a contractile reserve was not utilised. The differences observed in MVC and VA, which rely on 255 
voluntary maximal efforts, could suggest that central fatigue was greater following the deception trial. 256 
However, this was not a limiting factor to performance as participants significantly improved 257 
compared to a baseline trial without feedback (26). It is possible that the recreationally active 258 
participants in Ducrocq, Hureau (26) were consciously aware of the exaggerated fatigue in the 259 
deception trial, as evidenced by an increase in RPE, and consequently any reductions in voluntary 260 
force could be attributed to an increased perception of effort rather than an exaggerated disruption 261 
to peripheral homeostasis.  262 
 263 
Similar to the present study and others (27, 35), Konings, Parkinson (25) reported no differences in 264 
RPE when competing against an avatar of previous performance. They did however, find that 265 
potentiated doublet twitches were significantly smaller following a competitive trial, indicating that 266 
the improved performance was concurrent with additional peripheral fatigue.  In contrast, well-267 
trained cyclists in the present study did not improve performance or experience a greater degree of 268 
peripheral fatigue following accurate feedback, only improving performance following deceptive 269 
feedback. This might suggest that well-trained cyclists are able to tolerate an increased task demand 270 
without compromising their voluntary force capacity, and the reduced voluntary measures of 271 
neuromuscular fatigue observed by Ducrocq, Hureau (26) could be a consequence of a less-than-272 
maximal effort in an unaccustomed population, rather than a higher degree of neuromuscular fatigue 273 
per se. This can be seen by the ~30-40% decrease in MVC in the recreationally active cohort (26), 274 
compared to 22% in well-trained cyclists in the present study. The differences in end-exercise 275 
peripheral fatigue between the present study and Konings, Parkinson (25) might lie in the differences 276 
in training status. In the present study participants completed the 4 km TT in ~365 s, with a mean 277 
power output of ~325 W, compared to ~384 s and ~280 W in Konings, Parkinson (25).  278 
 279 
The lack of difference shown in post-exercise neuromuscular function in the present study, despite 280 
the improved performance, could be explained by the small differences observed between trials. It 281 
has previously been shown that the post-exercise degree of central and peripheral fatigue varies with 282 
task intensity and duration (10, 11). Whilst this would suggest that a difference might be seen, given 283 
that cyclists in the present study improved their performance, it is plausible that the small 10 W (3%) 284 
improvement in mean power output simply was not of a large enough magnitude to elicit a more 285 
substantial amount of neuromuscular fatigue. It could also be suggested that the efficacy of deception 286 
shown in the present and previous data, might not apply to longer duration time trials as the limiting 287 
factors to performance are different (11). An alternative explanation for the lack of difference could 288 
be that the methods used in the present study were not sensitive enough to detect any difference. 289 
Between-day reliability values (CV%) from the present study, along with previous work from our 290 
laboratories, indicate good or excellent reliability for outcome measures under study; MVC, 4.1 – 291 
5.9%; Qtw.pot, 4.8 – 6.6%; and VA, 1.7 – 3.1% (10, 36). Thus, the differences shown by Ducrocq et al. 292 
(2017) (MVC, +5%, VA, +4%) are on the limit of measurement error, and might not have been 293 
detectable in the present study. 294 
 295 
Another potential explanation for the lack of difference between trials could relate to the altered 296 
pacing strategy in the deception trial, which might have improved performance by ensuring a more 297 
optimal distribution of work, in a manner that would not necessarily lead to augmented 298 
neuromuscular fatigue. The lack of trial effect for mean power output showed that well-trained 299 
participants did not simply cycle faster for the entire time trial to beat the deceptively paced avatar. 300 
Alternatively, they might have altered their pacing strategy in order to perform a similar amount of 301 
work, but still beat the avatar. Recent evidence suggests that faster pulmonary oxygen kinetics during 302 
the initial stages of 6 mins of constant-load cycling leads to reduced peripheral fatigue at task 303 
termination (37). The present study utilised self-paced cycling of similar duration (~6 mins). Therefore, 304 
despite the non-significant interaction effect in power output, it might have been the case that 305 
increased power output in the initial stages of DEC (0 - 1200 m: mean difference 25 W, 8 out of 10 306 
participants) caused participants to reach peak aerobic energy production faster, reducing the reliance 307 
on anaerobic respiration, negating the need for a larger ‘end spurt’ to beat the avatar. This would 308 
negate the potentially deleterious effects one would expect from increased power output, 309 
paradoxically leading to no difference in post-exercise neuromuscular fatigue between trials, despite 310 
an improved performance. 311 
 312 
The present data suggest that a deceptively paced avatar is an effective way to improve 4 km TT 313 
performance in well-trained cyclists. However, unlike lesser-trained populations (25, 26), the 314 
mechanisms of performance enhancement are not due to augmented neuromuscular output and 315 
consequent fatigue. More likely, well-trained athletes alter the pacing strategy employed to beat an 316 
avatar of their previous best performance. Therefore, the use of surreptitiously altered avatar may 317 
not be an effective training method when intending to increase the metabolic and neuromuscular 318 
stress imposed on the athlete for a given task.  319 
 320 
One limitation of the present data was sample size, albeit 10 participants is comparable to the sample 321 
size of Ducrocq et al. (26): n=11 and Konings et al. (25): n=12. However, it may be the case that the 322 
ANOVA used to compare differences between trials was too robust to show differences. A post hoc 323 
power calculation was conducted using the trial*time interaction effect size (η2 = 0.122). The present 324 
data has a statistical power of 0.66, and a sample size of 13 would have achieved a statistical power 325 
of 0.8. Additionally, the difference in Qtw,pot reduction between BASE and DEC, appeared large enough 326 
(~7%) to reflect a meaningful change. However, when the individual changes in Qtw,pot reduction are 327 
plotted across trials, no clear trend was observed (data not shown). Furthermore, there was no 328 
correlation between differences in time to completion and Qtw,pot reduction (r2 = 0.13, P = 0.314). 329 
 330 
CONCLUSION 331 
The results of the present study suggest that improved performance via deception does not cause a 332 
critical threshold of peripheral fatigue to be exceeded in well-trained participants. More likely, the 333 
improved performance is due to alterations in pacing strategy. Future research should look to 334 
investigate the mechanisms underpinning performance enhancements via deceptive feedback and 335 
competition in athletes and non-athletes, as this remains unclear based on the current evidence. 336 
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Table and Figure Legends 442 
Table 1. Performance, rating of perceived exertion, and blood lactate responses to 4 km time-trials at 443 
baseline and with accurate and deceptive feedback. * P < 0.05 significantly different from pre-. 444 
 445 
Table 2. Measures of evoked EMG and within twitch variables pre and immediately post (< 1.5 min) 4 446 
km time-trials at baseline and with accurate and deceptive feedback. * P < 0.05 significantly different 447 
from pre. 448 
 449 
Figure 1. Power output during the 4 km time-trials displayed over 10% epochs. # = P < 0.05 significant 450 
interaction effect, * P < 0.05 deception significantly different from baseline. 451 
 452 
Figure 2. Changes in neuromuscular function from pre to post each time-trial. MVC, maximal voluntary 453 
contraction (A); VA, voluntary activation (B) and Qtw,pot, quadriceps potentiated twitch force (C).  For 454 
each variable, individual data are shown as the unfilled symbols and the group mean is shown as the 455 
filled symbols. 456 
Table 1. Performance, perceptual and haematological measures pre, during and post the 4 km 
time-trials at baseline and with accurate and deceptive feedback. 
 
 
Baseline Accurate Deception 
     Time to completion (s) 367 ± 15 365 ± 18      361 ± 17# 
          
     Mean power output (W) 324 ± 38 327 ± 42 334 ± 41 
          
     % maximum power  80 ± 7 81 ± 8 82 ± 7 
          
     Mean  RPE 8 ± 1 8 ± 1 8 ± 1 
          
     Blood Lactate (mmol·L-1) 
                   Pre 
                   Post 
 
1.88 
14.21 
 
± 
± 
 
0.50 
2.49* 
 
2.02 
15.11 
 
± 
± 
 
0.77 
1.72* 
 
1.71 
15.41 
 
± 
± 
 
0.46 
1.82*# 
          
Values are means ± SD for 10 participants.  RPE = rating of perceived exertion.  * P < 0.001 vs. Pre.  
# P < 0.05 vs. Baseline 
Table 1
 Table 2. Measures of evoked EMG and within twitch variables pre and immediately post (< 1.5 min) 4 km 
time-trials at baseline and with accurate and deceptive feedback. 
    Baseline Accurate Deception 
Mmax Amplitude Pre  9.1 ± 4.8  8.2 ± 3.6  9.2 ± 4.0 
 (mV) Post  9.5 ± 5.7  8.1 ± 3.6  8.7 ± 4.2 
         
 Area Pre  57.5 ± 29.6  56.5 ± 25.9  70.1 ± 36.1 
 (mV·s-1) Post  71.5 ± 54.5  60.9 ± 26.8  70.0 ± 38.6 
 
         
Within twitch 
Characteristics 
MRFD Pre  5001 ± 1214  4954 ± 1066  5552 ± 1472 
 (N·s-1) Post  2865 ± 720*  3105 ± 858*  2853 ± 843* 
         
 MRR Pre  −1398 ± 402  −1921 ± 543  −1628 ± 551 
 (N·s-1) Post  −1041 ± 429*  −1354 ± 442*  −1183 ± 643* 
         
 CT Pre  84 ± 10  84 ± 9  78 ± 11 
 (ms) Post  68 ± 6*  70 ± 7*  68 ± 4* 
         
 RT0.5 Pre  82 ± 19  83 ± 10  81 ± 12 
 (ms) Post  71 ± 19*  67 ± 14*  78 ± 17* 
Values are means ± SD for 10 participants.  Mmax, maximal M-wave; MRFD, maximum rate of force 
development; CT, contraction time; MRR, maximum relaxation rate; RT0.5, one-half relaxation time. * P <0.05 
different from pre. 
Table 2
Figure 1 Click here to download Figure Fig 1.tif 
Figure 2 Click here to download Figure Fig 2.tif 
